Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
15,447,782
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
4,110,603
-
Shares change
-
+157,461
-
Total reported value, excl. options
-
$44,065,987
-
Value change
-
+$1,682,020
-
Number of buys
-
27
-
Number of sells
-
-13
-
Price
-
$10.72
Significant Holders of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) as of Q2 2022
61 filings reported holding GRX - Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value as of Q2 2022.
Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,110,603 shares
of 15,447,782 outstanding shares and own 27% of the company stock.
Largest 10 shareholders include WELLS FARGO & COMPANY/MN (717,640 shares), LAZARD ASSET MANAGEMENT LLC (473,587 shares), MORGAN STANLEY (408,335 shares), GAMCO INVESTORS, INC. ET AL (327,732 shares), ROYAL BANK OF CANADA (304,622 shares), UBS Group AG (237,816 shares), Cetera Investment Advisers (171,947 shares), Aviance Capital Partners, LLC (170,241 shares), Cornerstone Advisors, LLC (170,043 shares), and BENNICAS & ASSOCIATES, INC. (167,400 shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.